Nederlands
Nederland
Aanmelden
De tip van euro-boek.nl
Soortgelijke boeken
Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:
Zoekfuncties
boekentips
actueel
Advertentie
FILTER
- 0 resultaten
laagste prijs: 58,80 €, hoogste prijs: 101,64 €, gemiddelde prijs: 81,37 €
Renal Anemia: Conflicts and Controversies
uitverkocht boek
(*)
Renal Anemia: Conflicts and Controversies - pocketboek

2010, ISBN: 9048160456, Lieferbar binnen 4-6 Wochen Verzendingskosten:Versandkostenfrei innerhalb der BRD

ID: 9789048160457

Internationaler Buchtitel. In englischer Sprache. Verlag: Springer-Verlag GmbH, Paperback, 160 Seiten, L=235mm, B=155mm, H=8mm, Gew.=252gr, [GR: 16960 - HC/Medizin/Andere Fachgebiete], Kartoniert/Broschiert, Klappentext: Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management. Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

Nieuw boek DEU
Buchgeier.com
Lieferbar binnen 4-6 Wochen (Besorgungstitel) Verzendingskosten:Versandkostenfrei innerhalb der BRD
Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Renal Anemia: Conflicts and Controversies - Onyekachi Ifudu (Editor)
uitverkocht boek
(*)
Onyekachi Ifudu (Editor):
Renal Anemia: Conflicts and Controversies - nieuw boek

ISBN: 9789048160457

Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management. Books Books ~~ Medicine~~ Nephrology Renal-Anemia~~Onyekachi-Ifudu Springer Netherlands Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

Nieuw boek [USA] Barnesandnoble.com
Free Shipping on eligible orders over $25 Verzendingskosten:exclusief verzendingskosten
Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Renal Anemia: Conflicts and Controversies - Onyekachi Ifudu
uitverkocht boek
(*)
Onyekachi Ifudu:
Renal Anemia: Conflicts and Controversies - pocketboek

2010, ISBN: 9789048160457

ID: 14929380

1st ed. Softcover of orig. ed. 2002, Softcover, Buch, [PU: Springer]

Nieuw boek Lehmanns.de
Verzendingskosten:Versand in 7-9 Tagen, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.

Bijzonderheden over het boek
Renal Anemia: Conflicts and Controversies

Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

Gedetalleerde informatie over het boek. - Renal Anemia: Conflicts and Controversies


EAN (ISBN-13): 9789048160457
ISBN (ISBN-10): 9048160456
pocket book
Verschijningsjaar: 2010
Uitgever: Springer-Verlag GmbH
160 Bladzijden
Gewicht: 0,252 kg
Taal: eng/Englisch

Boek bevindt zich in het datenbestand sinds 20.03.2011 04:49:56
Boek voor het laatst gevonden op 17.11.2016 15:07:04
ISBN/EAN: 9789048160457

ISBN - alternatieve schrijfwijzen:
90-481-6045-6, 978-90-481-6045-7


< naar Archief...
Verwante boeken